52 results
DEFR14A
ARAV
Aravive Inc
22 Sep 23
Revised proxy
5:04pm
in the footnotes to this table and subject to community property laws where applicable, we believe that each of the stockholders named in this table has sole
8-K
xtl 03nu8xgr
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-99.1
7lcv 71synvru
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
424B3
p8pqa0 h57t6aw
19 Jan 22
Prospectus supplement
4:05pm
8-K
EX-99.1
h90ry5me
9 Nov 21
3 of 5 (60%) patients achieved a partial response All 5 patients treated demonstrated tumor decrease from baseline
8:29am
8-K
EX-99.1
z81h4p
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
424B5
eo61zx
16 Feb 21
Prospectus supplement for primary offering
7:05am